Anti-EBOV glycoprotein Neutralizing Antibody (V3S-0723-FY2) (CAT#: V3S-0723-FY2)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description The mAb100 recognizes ebola virus (EBOV) glycoprotein and binds to the bases of the Ebola virus glycoprotein (GP) trimer. This antibody blocks access to the cathepsin cleavage loop, and prevents the proteolytic cleavage of GP required for viral entry. The antibody potently neutralizes multiple EBOV isolates and protects non-human primates against all symptoms of ebola virus disease, such as viremia.
Clonality Monoclonal
Host Species Human
Target Species Ebola Virus (EBOV)
Isotype IgG

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application ELISA; Neut; FuncS

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target EBOV glycoprotein
Alternative Name Second secreted glycoprotein; small secreted glycoprotein; spike glycoprotein
Gene ID 911829
UniProt Q05320
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry